Wednesday, 02 July 2025 14:59
APPROVAL FOR SLEEP APNOEA DRUG
THE TGA has approved Mounjaro (tirzepatide), a drug used for type 2 diabetes and obesity, to also treat moderate-to-severe obstructive sleep apnoea (OSA) in adults with obesity. OSA affects 780,000 Australians and is linked to serious health risks. Mounjaro works by promoting weight loss, reducing airway blockages. It’s the first approved medicine for OSA in Australia, offering an alternative to CPAP machines and surgery. Experts hail it as a major breakthrough for sleep and obesity-related health care.
Published in
Default Set
Wednesday, 02 July 2025 14:57
CHARITY SUPPORT REACHES NEW LEVELS
THE 11th Australian Charities Report reveals strong growth in the sector, with charity revenue reaching a record $222B—up 10.7%—and staff numbers increasing by over 70,000. Charities now employ 1.54 million people, outpacing construction and manufacturing. Volunteer numbers rose to 3.77 million. While revenue growth was led by extra large charities, many small charities struggled. Rising demand, driven by cost-of-living pressures, continues to challenge capacity.
Published in
Default Set
Wednesday, 02 July 2025 14:52
PARENTAL CONCCERN IS MEDICALLY VALID
A NEW study in The Lancet Child & Adolescent Health shows that parental concern about a child worsening in hospital is as significant as abnormal vital signs in detecting serious illness. Led by Monash University researchers, the study urges clinicians to ask, “Are you worried your child is getting worse?” during checks. Findings revealed worried parents were four times more likely to have children needing intensive care, highlighting the need to formally integrate caregiver input into hospital early warning systems.
Published in
Default Set
